Cidara Therapeutics Inc.

NASDAQ: CDTX · Real-Time Price · USD
24.03
-0.02 (-0.08%)
At close: Jun 05, 2025, 3:59 PM
24.05
0.08%
After-hours: Jun 05, 2025, 04:10 PM EDT

Cidara Therapeutics Statistics

Share Statistics

Cidara Therapeutics has 12.97M shares outstanding. The number of shares has increased by 140.12% in one year.

12.97M
140.12%
55.44%
99.99%
n/a
96
0.06%

Short Selling Information

The latest short interest is 445.33K, so 3.43% of the outstanding shares have been sold short.

445.33K
3.43%
3.44%
4.33

Valuation Ratios

The PE ratio is -1.01 and the forward PE ratio is -2.66. Cidara Therapeutics's PEG ratio is 0.

-1.01
-2.66
133.87
2.4
1.05
-0.97
0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Cidara Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 4.25, with a Debt / Equity ratio of 0.02.

4.25
4.25
0.02
-0.02
-0.02
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$33,552.63
$-4,469,131.58
38
0.01
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by 96.32% in the last 52 weeks. The beta is 0.8, so Cidara Therapeutics's price volatility has been higher than the market average.

0.8
96.32%
21.01
18.42
57.34
160,976

Income Statement

In the last 12 months, Cidara Therapeutics had revenue of 1.27M and earned -169.83M in profits. Earnings per share was -26.75.

1.27M
1.04M
-176.1M
-169.83M
-176.1M
-176.1M
-26.75
Full Income Statement

Balance Sheet

The company has 189.82M in cash and 3.58M in debt, giving a net cash position of 186.25M.

189.82M
3.58M
186.25M
-611.26M
191.73M
140.04M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -176.53M and capital expenditures -129K, giving a free cash flow of -176.66M.

-176.53M
-129K
-176.66M
-27.82
Full Cash Flow Statement

Margins

Gross margin is 81.73%, with operating and profit margins of -13811.92% and -13319.76%.

81.73%
-13811.92%
-13356.16%
-13319.76%
-13811.92%
-13811.92%
-13855.84%

Dividends & Yields

CDTX does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for CDTX is $45, which is 83.4% higher than the current price. The consensus rating is "Strong Buy".

$45
83.4%
Strong Buy
8
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Apr 24, 2024. It was a backward split with a ratio of 1:20.

Apr 24, 2024
backward
1:20

Scores

-2.09
1